Collectively, these in vitro findings suggest that liraglutide alleviates ox-LDL-induced endothelial dysfunction through GLP-1R-dependent down-regulation of the LOX-1/NOX4/NF-κB signaling pathway. This evidence concerns the gene GLP1R and endothelial dysfunction.